--- title: "Enovis | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 589.15 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/285527051.md" datetime: "2026-05-07T10:12:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285527051.md) - [en](https://longbridge.com/en/news/285527051.md) - [zh-HK](https://longbridge.com/zh-HK/news/285527051.md) generator: "portal-rs" --- # Enovis | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 589.15 M Revenue: As of FY2026 Q1, the actual value is USD 589.15 M, beating the estimate of USD 572.44 M. EPS: As of FY2026 Q1, the actual value is USD -0.15, missing the estimate of USD 0.0033. EBIT: As of FY2026 Q1, the actual value is USD 15.7 M. #### First Quarter 2026 Financial Results **Net Sales**Enovis Corporation reported first-quarter net sales of $589 million, representing a 5% increase on a reported basis and a 3% increase on an organic basis compared to the same quarter in 2025 . **Segment Revenue and Growth** **Reconstructive Segment:** Net sales grew 11% on a reported basis to $317.1 million and 6% on an organic basis compared to $286.3 million in the first quarter of 2025 . **Prevention and Recovery (P&R) Segment:** Net sales were flat on a reported basis at $272.0 million and grew 1% on an organic basis compared to $272.6 million in the first quarter of 2025 . **Profitability Metrics (GAAP)** **Net Loss:** The company reported a net loss of -$8,450 thousand for the first quarter of 2026, a significant improvement from the -$55,705 thousand net loss in the first quarter of 2025 . **Net Loss Margin:** The net loss margin was -1.4% of sales in Q1 2026, compared to -10.0% in Q1 2025 . **Gross Profit:** Gross profit for Q1 2026 was $365,485 thousand, up from $332,229 thousand in Q1 2025 . **Gross Profit Margin:** The gross profit margin was 62.0% in Q1 2026, an increase from 59.5% in Q1 2025 . **Operating Income (Loss):** Operating income was $6,530 thousand in Q1 2026, a substantial improvement from an operating loss of -$46,769 thousand in Q1 2025 . **Operating Income (Loss) Margin:** The operating income margin was 1.1% in Q1 2026, compared to an operating loss margin of -8.4% in Q1 2025 . **Profitability Metrics (Non-GAAP)** **Adjusted EBITDA:** Adjusted EBITDA reached $103.6 million in Q1 2026, up from $87.1 million in Q1 2025 . **Adjusted EBITDA Margin:** The adjusted EBITDA margin was 17.6% of sales in Q1 2026, an increase from 15.6% in Q1 2025 . **Adjusted Gross Profit:** Adjusted gross profit was $366.1 million in Q1 2026, compared to $332.8 million in Q1 2025 . **Adjusted Gross Profit Margin:** The adjusted gross profit margin was 62.1% in Q1 2026, up from 59.6% in Q1 2025 . **Adjusted Net Income:** Adjusted net income from continuing operations was $51.6 million in Q1 2026, an increase from $37.3 million in Q1 2025 . **Adjusted Net Income Margin:** Adjusted net income margin was 8.8% in Q1 2026, up from 6.7% in Q1 2025 . **Cash Flow** **Net Cash Provided by Operating Activities:** Net cash provided by operating activities was $23,951 thousand in Q1 2026, a significant improvement from net cash used in operating activities of -$1,596 thousand in Q1 2025 . **Key Expenses** **Cost of Sales:** $223,666 thousand in Q1 2026 versus $226,605 thousand in Q1 2025 . **Selling, General and Administrative Expense:** $282,810 thousand in Q1 2026 versus $269,019 thousand in Q1 2025 . **Research and Development Expense:** $31,533 thousand in Q1 2026 versus $28,528 thousand in Q1 2025 . **Amortization of Acquired Intangibles:** $41,904 thousand in Q1 2026 versus $41,812 thousand in Q1 2025 . **Restructuring Charges:** $2,708 thousand in Q1 2026 versus $3,862 thousand in Q1 2025 . **Interest Expense, Net:** $9,169 thousand in Q1 2026 versus $9,188 thousand in Q1 2025 . **Other (Income) Expense, Net:** -$3,273 thousand in Q1 2026 versus $1,392 thousand in Q1 2025 . **Income Tax Expense (Benefit):** $9,045 thousand in Q1 2026 versus -$1,769 thousand in Q1 2025 . **Stock-Based Compensation Expense:** $8,750 thousand in Q1 2026 versus $7,407 thousand in Q1 2025 . **Depreciation and Amortization:** $73,355 thousand in Q1 2026 versus $71,435 thousand in Q1 2025 . #### 2026 Financial Outlook Enovis Corporation reaffirms its financial expectations for 2026 . The company anticipates revenue to be approximately $2.31-2.37 billion, which includes an organic revenue growth of 4-6% . Adjusted EBITDA is projected to be in the range of $425-435 million, and full-year free cash flow conversion is expected to be 25% or higher . ### Related Stocks - [ENOV.US](https://longbridge.com/en/quote/ENOV.US.md) ## Related News & Research - [Weekly Recap: 2026 organic revenue outlook raised and DKK1.0bn share buyback](https://longbridge.com/en/news/296738910.md) - [05:00 ETHTZ Deadline: HTZ Investors Have Opportunity to Lead Hertz Global Holdings, Inc. Securities Fraud Lawsuit](https://longbridge.com/en/news/296760595.md) - [14:55 ETPRIM Deadline: PRIM Investors with Losses in Excess of $100K Have Opportunity to Lead Primoris Services Corporation Securities Fraud Lawsuit](https://longbridge.com/en/news/296645027.md) - [14:50 ETGDDY Investors Have Opportunity to Lead GoDaddy Inc. Securities Fraud Lawsuit](https://longbridge.com/en/news/296820357.md) - [09:13 ETSMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit](https://longbridge.com/en/news/296682880.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**